A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

Completed · Phase 2

Conditions studied: Macular Degeneration

In brief

The objective of this study is to evaluate abicipar pegol for safety and treatment effects in participants with neovascular age-related macular degeneration (AMD).

Key facts

Study ID

NCT03539549

Run by

Allergan

People needed

124

Starts

2018-05-25

Expected to finish

2019-02-27

Last updated by the study team

2020-08-03

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants, 50 years of age or older at the time of informed consent
• Best Corrected Visual Acuity (BCVA) ≤ 78 and ≥ 24 letters (20/32 to 20/320 Snellen equivalents, respectively) at Screening and at Baseline (Day 1, prior to treatment) visits in the study eye
• BCVA of 34 letters (Snellen equivalent 20/200) or better at Baseline (Day 1, prior to treatment) in the non-study eye

You may not qualify if…

• Active periocular, ocular, or intraocular infection at baseline (Day 1) (either eye)
• Previous or concurrent macular laser treatment (study eye)
• Cataract or refractive surgery within 3 months prior to baseline (study eye)

Where it is running

• Barnet Dulaney Perkins Eye Center — Phoenix, Arizona, United States
• Retina Associates Southwest, PC — Tucson, Arizona, United States
• Win Retina — Arcadia, California, United States
• Retina Consultants of Orange County — Fullerton, California, United States
• Mark B. Kislinger, MD, Inc. — Glendora, California, United States
• Atlantis Retina Institute (Atlantis Eyecare) — Huntington Beach, California, United States
• N. California Retina Vitreous Associates Medical Group, INC. — Mountain View, California, United States
• California Eye Specialists Medical Group, Inc — Pasadena, California, United States
• Retinal Consultants Medical Group, Inc. — Sacramento, California, United States
• Colorado Retina Associates — Golden, Colorado, United States
• Retina Specialty Institute — Pensacola, Florida, United States
• Retina Vitreous Associates of Florida — St. Petersburg, Florida, United States
• Center for Retina and Macular Disease — Winter Haven, Florida, United States
• Georgia Retina, P.C. — Marietta, Georgia, United States
• Marietta Eye Clinic — Marietta, Georgia, United States
• Gailey Eye Clinic — Bloomington, Illinois, United States
• Raj K. Maturi, MD, PC — Indianapolis, Indiana, United States
• Sabates Eye Center — Leawood, Kansas, United States
• Sierra Eye Associates — Reno, Nevada, United States
• Capital Region Retina, PLLC — Albany, New York, United States
• Ophthalmic Consultants of Long Island — Lynbrook, New York, United States
• Retina Associates of Western New York — Rochester, New York, United States
• Retina Vitreous Surgeons of Central NY, P.C. — Syracuse, New York, United States
• Cincinnati Eye Institute — Cincinnati, Ohio, United States
• Pennsylvania Retina Specialists, P.C. — Camp Hill, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.